Between disputed claims, unconstitutional payments and the new global push for higher prices, the PBS rebate system sits on increasingly shaky ground. It has delivered access and spending control, and might be more important than ever, given global shifts by US frustration, but it has the appearance of a complete mess.
What next for PBS rebate system amid constitutional breaches, disputed claims, and global pressure?
November 6, 2025 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
US pricing push gets real with Australia included in comparison list
December 22, 2025 - - Latest News -
Parsimony has unfortunately become an enduring test of the institution's legitimacy
December 20, 2025 - - Latest News -
PBAC delivers a broad range of outcomes in November, including for obesity
December 20, 2025 - - Latest News -
Takeda’s next-generation psoriasis therapy delivers landmark Phase 3 results
December 19, 2025 - - Latest News -
A 'fit for purpose' HTA system will be accompanied by a 'fit for purpose' cost recovery framework
December 19, 2025 - - Latest News -
Cleo Diagnostics raises funds to accelerate US launch and advance ovarian cancer screening
December 18, 2025 - - Australian Biotech -
Actinogen crosses key milestone as pivotal Alzheimer’s trial fully enrols
December 18, 2025 - - Australian Biotech

